Share

Networks

Clinical Studies (2)

  • Mikulska : Study aims to report the efficacy and safety of triple combination therapy in severely immunocompromised patients with SARS-CoV-2 infection
  • mpox-ICONA : Study aims to assess mpox disease, which recognises an epidemiological network that overlaps with HIV. To identify predictors of severe evolution and disease duration in mpox cases, as well as to test the association between mpox severity and viral load in biological fluids

Study Data

  • Adults
  • Elderly
  • Fragile population
  • People at high risk of STIs
  • Immunocompromised host
  • People living with HIV
  • Hospital wide
  • Infectious diseases unit
  • SARS-CoV-2
  • Monkeypox virus
  • Acute COVID-19
  • Mpox
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir
  • Remdesivir
  • Molnupiravir

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to